ATE355288T1 - COMPOUNDS AND THERAPEUTIC METHODS - Google Patents
COMPOUNDS AND THERAPEUTIC METHODSInfo
- Publication number
- ATE355288T1 ATE355288T1 AT00926538T AT00926538T ATE355288T1 AT E355288 T1 ATE355288 T1 AT E355288T1 AT 00926538 T AT00926538 T AT 00926538T AT 00926538 T AT00926538 T AT 00926538T AT E355288 T1 ATE355288 T1 AT E355288T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- therapeutic methods
- treatment
- diseases
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- ZXCZNUMWHATQSR-UHFFFAOYSA-N 10,20-diazapentacyclo[11.8.0.03,11.04,9.014,19]henicosa-1(13),3,5,7,9,11,14,16,18,20-decaene Chemical class C1=NC2=CC=CC=C2C2=C1CC1=C(C=CC=C3)C3=NC1=C2 ZXCZNUMWHATQSR-UHFFFAOYSA-N 0.000 abstract 1
- 241000224482 Apicomplexa Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
The present invention relates to indolo[3,2-j]phenanthridine compounds and their use in the treatment of cancer and other diseases of humans and animals including parasitic diseases such as those of Apicomplexan origin, compositions containing said compounds and methods of treatment using them.</PTEXT>
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ0373A AUPQ037399A0 (en) | 1999-05-14 | 1999-05-14 | Novel compounds and therapeutic methods |
AUPQ0506A AUPQ050699A0 (en) | 1999-05-21 | 1999-05-21 | Novel compounds and therapeutic methods-ii |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE355288T1 true ATE355288T1 (en) | 2006-03-15 |
Family
ID=25646057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00926538T ATE355288T1 (en) | 1999-05-14 | 2000-05-12 | COMPOUNDS AND THERAPEUTIC METHODS |
Country Status (7)
Country | Link |
---|---|
US (1) | US6632822B1 (en) |
EP (1) | EP1178988B1 (en) |
JP (1) | JP2002544275A (en) |
AT (1) | ATE355288T1 (en) |
CA (1) | CA2372032A1 (en) |
DE (1) | DE60033649D1 (en) |
WO (1) | WO2000069856A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962023B2 (en) | 2004-09-28 | 2015-02-24 | Atrium Medical Corporation | UV cured gel and method of making |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
WO2006036967A1 (en) * | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
CA2626030A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
WO2008057344A2 (en) | 2006-11-06 | 2008-05-15 | Atrium Medical Corporation | Coated surgical mesh |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
CA2764653C (en) | 2009-06-10 | 2018-01-02 | Chugai Seiyaku Kabushiki Kaisha | Tetracyclic compounds |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
EP2606886B1 (en) | 2010-08-20 | 2020-01-08 | Chugai Seiyaku Kabushiki Kaisha | Composition comprising tetracyclic compound |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
CA3077553C (en) | 2012-09-25 | 2022-08-02 | Chugai Seiyaku Kabushiki Kaisha | Ret inhibitor |
AU2015250574B2 (en) | 2014-04-25 | 2020-07-16 | Chugai Seiyaku Kabushiki Kaisha | Preparation containing tetracyclic compound at high dose |
CA2946268A1 (en) | 2014-04-25 | 2015-10-29 | Chugai Seiyaku Kabushiki Kaisha | Crystal of tetracyclic compound |
TWI718102B (en) | 2014-08-08 | 2021-02-11 | 日商中外製藥股份有限公司 | Amorphous body of tetracyclic compound |
US11077093B2 (en) | 2015-01-16 | 2021-08-03 | Chugai Seiyaku Kabushiki Kaisha | Combination drug |
AR116113A1 (en) | 2018-09-04 | 2021-03-31 | Chugai Pharmaceutical Co Ltd | METHOD FOR MANUFACTURING A TETRACYCLIC COMPOUND |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU743899B2 (en) | 1997-07-18 | 2002-02-07 | Georgetown University | Bicyclic metabotropic glutamate receptor ligands |
AU1153601A (en) | 1999-10-29 | 2001-05-08 | Merck Sharp & Dohme Limited | Method to treat pain utilizing benzimidazole NMDA NR2B antagonists |
-
2000
- 2000-05-12 CA CA002372032A patent/CA2372032A1/en not_active Abandoned
- 2000-05-12 JP JP2000618273A patent/JP2002544275A/en not_active Withdrawn
- 2000-05-12 DE DE60033649T patent/DE60033649D1/en not_active Expired - Lifetime
- 2000-05-12 US US09/980,506 patent/US6632822B1/en not_active Expired - Fee Related
- 2000-05-12 AT AT00926538T patent/ATE355288T1/en not_active IP Right Cessation
- 2000-05-12 EP EP00926538A patent/EP1178988B1/en not_active Expired - Lifetime
- 2000-05-12 WO PCT/AU2000/000458 patent/WO2000069856A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE60033649D1 (en) | 2007-04-12 |
EP1178988A4 (en) | 2004-10-06 |
CA2372032A1 (en) | 2000-11-23 |
EP1178988A1 (en) | 2002-02-13 |
JP2002544275A (en) | 2002-12-24 |
EP1178988B1 (en) | 2007-02-28 |
US6632822B1 (en) | 2003-10-14 |
WO2000069856A1 (en) | 2000-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE355288T1 (en) | COMPOUNDS AND THERAPEUTIC METHODS | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
DE60029799D1 (en) | COMPOUNDS, PROCESSES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CELL DAMAGE SUCH AS, FOR EXAMPLE, DAMAGE TO NERVE OR CANDLE TISSUE | |
ATE339406T1 (en) | CHINAZOLINE COMPOUNDS AS REMEDIES | |
DE60038183D1 (en) | COMPOUNDS AND COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | |
ME00513B (en) | Azabicycloalkanes as ccr5 modulators | |
TR199903331T2 (en) | Farnesil protein transferase inhibitors. | |
HK1069316A1 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
MXPA02006029A (en) | Novel lipopeptides as antibacterial agents. | |
MXPA02006030A (en) | Lipopeptides as antibacterial agents. | |
ATE355374T1 (en) | THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC DISEASES | |
IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
HK1021699A1 (en) | Pentafluorobenzenesulfonamides and analogs. | |
AU3304400A (en) | Tetrahydropyran derivatives and their use as therapeutic agents | |
IS6558A (en) | Mixed disease treatment with vasoconstrictor | |
YU13301A (en) | Muscarinic agonists and antagonists | |
ES2144054T3 (en) | TRI COMPLEXES (PLATINUM). | |
SE0003476D0 (en) | Compounds | |
TR200103638T2 (en) | IL-8 Receptor antagonists | |
DE69612056D1 (en) | TERPEN DERIVATIVES (SARCODICTYINE) AS AN ANTICRECELLENT | |
MXPA06007007A (en) | Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours. | |
ATE187956T1 (en) | SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS | |
ATE306283T1 (en) | BIOTIN DERIVATIVES AND THEIR CONJUGATES WITH CHELATING AGENTS | |
ATE404550T1 (en) | CHEMICAL COMPOUNDS | |
AU7079300A (en) | Compositions and methods for the treatment of immune related diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |